title: Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.
authors.affiliation: Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. kaneto@medone.med.osaka-u.ac.jp
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kaneto
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Nakatani
authors.forename: Takeshi
authors.initials: T
authors.lastname: Miyatsuka
authors.forename: Dan
authors.initials: D
authors.lastname: Kawamori
authors.forename: Taka-aki
authors.initials: TA
authors.lastname: Matsuoka
authors.forename: Munehide
authors.initials: M
authors.lastname: Matsuhisa
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Kajimoto
authors.forename: Hidenori
authors.initials: H
authors.lastname: Ichijo
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Yamasaki
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Hori
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D015153:Blotting, Western; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D016650:Fluorescein-5-isothiocyanate; D015316:Genetic Therapy; D047468:Immunoprecipitation; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D048055:Mitogen-Activated Protein Kinase 8 / Q000037:antagonists & inhibitors*; D008969:Molecular Sequence Data; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014162:Transfection
chemical_list: D010455:Peptides; D048055:Mitogen-Activated Protein Kinase 8; D016650:Fluorescein-5-isothiocyanate